BCLI
BRAINSTORM CELL THERAPUTC
BCLI
BCLI
Delisted
BCLI was delisted on the 17th of July, 2025.
26 hedge funds and large institutions have $4.65M invested in BRAINSTORM CELL THERAPUTC in 2017 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 4 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
0.16% less ownership
Funds ownership: 0.55% → 0.39% (-0.16%)
4% less funds holding
Funds holding: 27 → 26 (-1)
Holders
26
Holding in Top 10
–
Calls
$335K
Puts
$8K
Top Buyers
| 1 | +$327K | |
| 2 | +$248K | |
| 3 | +$74K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$51.3K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$44K |
Top Sellers
| 1 | -$1.02M | |
| 2 | -$771K | |
| 3 | -$16K | |
| 4 |
Creative Planning
Overland Park,
Kansas
|
-$3K |
| 5 |
AIM
Acrospire Investment Management
Chicago,
Illinois
|
-$2.57K |